Urology

A recent subgroup analysis has provided crucial insights into the safety of extended lymph node dissection.

A randomised clinical trial has found that D-mannose does not live up to its promise.

A retrospective review reveals brachytherapy may elevate long-term pelvic second malignancy risk compared to radical prostatectomy, urging continued screening and education.

The ProScreen trial introduces a three-step prostate cancer screening method, offering potential to detect aggressive cancers while reducing unnecessary diagnoses. Read more.

Racial disparities continue to affect patient outcomes following a diagnosis of prostate cancer. A recent study finds Black males with prostate cancer have worse microvascular function than White males, potentially heightening cardiovascular disease risk.

A new research finds urinary microbiomes with fewer Lactobacilli and higher bacterial diversity are linked to more severe urinary incontinence episodes in women. Read more.

The ProBE-PC randomised clinical trial set out to determine the efficacy of transrectal biopsy versus transperineal biopsy in detecting clinically significant prostate cancer, infectious complications, and toxicity.

Pregnancy and childbirth have been shown not to increase the risk of recurrence of stress urinary incontinence (SUI), despite common belief amongst clinicians. Read more.